Gene · 9020
Papers3,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL. | Cell Death Dis | 2025 | 40819126 | PubTator, text mining | PubMed |
| Regulatory roles of circular RNAs in Wnt and other oncogenic signaling pathways in breast cancer progression: a comprehensive review. | Eur J Med Res | 2025 | 40804731 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| NfκBin: a machine learning based method for screening TNF-α induced NF-κB inhibitors. | Front Bioinform | 2025 | 40746657 | PubTator, text mining | PubMed |
| Circulating miRNAs as potential non-invasive biomarkers for ANCA-associated glomerulonephritis. | Front Immunol | 2025 | 40746566 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma. | Blood Cancer J | 2025 | 40739087 | PubTator, text mining | PubMed |
| Raf-kinase inhibitor protein (RKIP): A therapeutic target in colon cancer. | Biochim Biophys Acta Rev Cancer | 2025 | 40681057 | PubTator, text mining | PubMed |
| Transcriptomic Profile of Oral Cancer Lesions: A Proof-of-Concept Pilot Study of FFPE Tissue Sections. | Int J Mol Sci | 2025 | 40650045 | PubTator, text mining | PubMed |
| Polymorphisms rs2074292 of the MAP3K14 Gene and rs1883832 of the CD40 Gene and Breast Cancer in Women in Burkina Faso: A Case-Control Study. | Health Sci Rep | 2025 | 40636541 | PubTator, text mining | PubMed |
| Integrating network toxicology, transcriptomics, and metabolomics uncovers the hepatotoxic mechanisms of okadaic acid in LO2 cells. | Ecotoxicol Environ Saf | 2025 | 40561608 | PubTator, text mining | PubMed |
| High levels of EPSTI1 enhance IFN-β-mediated HLA-A expression and chemokine secretion in myoblasts in dermatomyositis. | Rheumatology (Oxford) | 2025 | 40459882 | PubTator, text mining | PubMed |
| The NF-κB signaling network in the life of T cells. | Front Immunol | 2025 | 40370445 | PubTator, text mining | PubMed |
| A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes. | Blood | 2025 | 40332467 | PubTator, text mining | PubMed |
| Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis. | Mol Neurobiol | 2025 | 40327306 | PubTator, text mining | PubMed |
| Inflammation and cancer cell survival: TRAF2 as a key player. | Cell Death Dis | 2025 | 40229245 | PubTator, text mining | PubMed |
| BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma. | Mol Cancer | 2025 | 40223121 | PubTator, text mining | PubMed |
| GS143, an inhibitor of E3 ligase β-TrCP, reverses HIV-1 latency without activating T cells via unconventional activation of NFκB. | PLoS Pathog | 2025 | 40168443 | PubTator, text mining | PubMed |
| Identification of a novel allosteric binding site on the catalytic domain of NF-κB inducing kinase (NIK). | RSC Med Chem | 2025 | 39990163 | PubTator, text mining | PubMed |
| RETRACTION: NIK-Mediated Reactivation of SIX2 Enhanced the CSC-like Traits of Hepatocellular Carcinoma Cells Through Suppressing Ubiquitin-Proteasome System. | Environ Toxicol | 2025 | 39957285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9020/papers?page=4